Consistent with this, pRb2/p130 over-expression in HepG2 HCC cell lines results in G0/G1 cell cycle arrest, growth inhibition in vitro and in vivo, while its down-regulation appears thus implicated in the progression of the disease [39]. This evidence concerns the gene RBL2 and hepatocellular carcinoma.